Clinical Trial Update: Application Of Autologous Blood Products During Modified Radical Mastectomy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the use of autologous blood products during modified radical mastectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Marshall University | Conditions: Mastectomy | Phase 3 | Status: UNKNOWN